Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit.
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit.
Journal: Cancer research communications
Published: January 17, 2023
Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit.
Journal: Communications medicine
Published: January 25, 2022
Barriers and facilitators to the use of survivorship care plans by hematopoietic stem cell transplant survivors and clinicians.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: May 12, 2021
Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 13, 2021
Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.
Journal: JCO precision oncology
Published: November 19, 2020
Impact of Survivorship Care Plans and Planning on Breast, Colon, and Prostate Cancer Survivors in a Community Oncology Practice.
Journal: Journal of cancer education : the official journal of the American Association for Cancer Education
Published: January 06, 2019
Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 18, 2018
Showing 1-7 of 7
Last Updated: 09/26/2026